Research Grant
[Cite as https://purl.org/au-research/grants/nhmrc/630483]
Researchers:
Prof Lisa Maher
(Principal investigator)
,
Dr Thomas Kerr
,
Ms Annie Madden
,
Prof Kimberly Page
,
Prof Margaret Hellard
View all 6 related researchers
Brief description Injecting drug users (IDU) are a key target group for new vaccines designed to prevent hepatitis C virus (HCV) infection. This study will establish the feasibility of conducting HCV vaccine trials in IDUs by answering key scientific questions, generating data to inform trial design and evaluation, establishing a partnership between leading international researchers and the peak Australian body for people who inject drugs, and providing the foundation for a global HCV prevention trial network.
Funding Amount $AUD 820,767.49
Funding Scheme NHMRC Project Grants
Notes Standard Project Grant
- nhmrc : 630483
- PURL : https://purl.org/au-research/grants/nhmrc/630483
